Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group to Omnicell

NEW YORK–(BUSINESS WIRE)–Oct 2, 2020– Today, Blue Wolf Capital Partners (“Blue Wolf”), a New York-based private equity firm, announced the completion of the sale of Pharmaceutical Strategies Group’s 340B business (“PSG”) to Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and […]

Click here to view original web page at apnews.com